Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
BMY Rating Summary
BMY Price Target Summary
- Highest: $80.00 (UBS)
- Lowest: $40.00 (Morgan Stanley)
- Average: $64.85
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$64.85 (-2.9%)
* Over Last 12-Mos
Rating Score: 3.2 / 10
Percentile Rank: 27%
Rating Score: 3.2 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/5/2026 | Argus | Jasper | Upgrade | Buy (Hold) |
75.00 (N/A) |
65.89 (66.81) |
1.4% | Details |
| 2/24/2026 | RBC Capital » Updated 8/4/2026 |
Trung Huynh | New Coverage | Sector Perform (N/A) |
64.00 (N/A) |
61.25 (66.81) |
9.08% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
